MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$19,854,723
Cash and cash
equivalents
$5,882,498
Other current assets
$852,036
Prepaid expenses
$504,890
Total current assets
$27,094,147
Property and equipment,
net
$898,930
Operating lease
right-of-use asset
$266,646
Other assets
$53,910
Total assets
$28,313,633
Total liabilities and
stockholders equity
$28,313,633
Total stockholders
equity
$20,024,175
Total liabilities
$8,289,458
Accumulated deficit
-$186,874,486
Additional
paid-in-capital
$206,865,282
Total current
liabilities
$8,205,459
Operating lease
liability, net of current...
$83,999
Common stock, 0.001 par
value 100,000,000...
$33,379
Other current
liabilities
$2,643,840
Estimate for accrued
legal contingencies...
$2,069,067
Accounts payable
$2,033,431
Accrued payroll
liabilities
$1,269,474
Operating lease
liability, current portion
$189,647
Back
Back
Balance Sheet
source: myfinsight.com
Skye Bioscience, Inc. (SKYE)
Skye Bioscience, Inc. (SKYE)